Coronary bypass or stent? The results are in

CABG best for patients with diabetes and multi-vessel disease

Coronary artery bypass grafting beats stenting in patients with multi-vessel disease and comorbid diabetes, conclude the authors of a systematic review.

The international study is the first to compare five-year all-cause mortality for the two procedures using data from 11,518 patients randomised to either coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI).

It shows that patients with multi-vessel disease and diabetes do better with CABG, with a 10% five-year all-cause mortality rate for CABG compared with 15.5% for PCI.

And the gap in